AURA

Aura Biosciences Inc
10.58
0.51 (5.06%)
Company Name Stock Ticker Symbol Market Type
Aura Biosciences Inc AURA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.51 5.06% 10.58 20:00:00
Open Price Low Price High Price Close Price Prev Close
10.02 10.02 10.66 10.58 10.07
more quote information »

Recent News

Date Time Source Heading
1/23/202318:39EDGARStatement of Changes in Beneficial Ownership (4)
1/23/202318:37EDGARStatement of Changes in Beneficial Ownership (4)
1/23/202318:36EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202317:56EDGARStatement of Changes in Beneficial Ownership (4)
12/15/202218:16EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202216:31EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/01/202216:55EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/30/202220:50BWAura Biosciences Announces Pricing of Public Offering of..
11/30/202216:01BWAura Biosciences Announces Proposed Public Offering of..
11/13/202222:57TRMNAura Biosciences Inc (AURA) Gets a Buy from SVB Securities
11/11/202201:21TRMNAnalysts Offer Insights on Healthcare Companies: Athira..
11/10/202207:12EDGARQuarterly Report (10-q)
11/10/202207:07EDGARCurrent Report Filing (8-k)
11/10/202207:00BWAura Biosciences Reports Third Quarter 2022 Financial..
11/10/202206:45BWAura Announces Global Phase 3 Trial Design with..
11/03/202207:00BWAura Biosciences to Participate in Upcoming Investor..
10/04/202207:05GLOBEPositive Data Presentations at AAO Annual Meeting..
10/03/202215:54TRMNAura Biosciences (NASDAQ:AURA) Stock Craters; Here’s Why
10/03/202207:07EDGARCurrent Report Filing (8-k)
10/03/202207:00BWAura Biosciences Announces Interim Phase 2 Data Evaluating..
9/28/202208:44EDGARCurrent Report Filing (8-k)
9/28/202207:00BWAura Biosciences Announces First Patient Dosed in Phase 1..
9/27/202207:00BWAura Biosciences to Present Ongoing Phase 2 Data Evaluating..
9/26/202200:25TRMNJMP Securities Sticks to Their Buy Rating for Aura..
9/07/202207:00BWAura Biosciences to Present Phase 2 Safety Data Evaluating..
9/01/202207:00BWAura Biosciences to Present Belzupacap Sarotalocan (AU-011)..
8/16/202204:46TRMNAura Biosciences Inc (AURA) Receives a Buy from SVB..
8/11/202216:30EDGARQuarterly Report (10-q)
8/11/202216:15BWAura Biosciences Reports Second Quarter 2022 Financial..
8/02/202207:00BWAura Biosciences to Participate at the 2022 BTIG..
7/19/202200:45TRMNAura Biosciences Inc (AURA) Has a New Rating from JMP..
6/30/202213:58DJNAura Biosciences Shares Rise 8% After Cancer Treatment Gets..
6/30/202207:44DJNAura Biosciences Gets Fast Track Designation for AU-011..
6/30/202207:00BWAura Biosciences Receives FDA Fast Track Designation for..
6/22/202216:30BWAura Biosciences Reports Topline Data from a Retrospective..
6/17/202217:10EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:08EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:08EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202207:00BWAura Biosciences to Present Updated Belzupacap Sarotalocan..
5/27/202206:09EDGARCurrent Report Filing (8-k)
5/26/202217:26BWAura Biosciences Announces Publication of Preclinical Data..
5/25/202207:00BWAura Biosciences to Participate in Upcoming Investor..
5/18/202216:07EDGARCurrent Report Filing (8-k)
5/14/202200:16TRMNAura Biosciences Inc (AURA) Receives a Buy from SVB..
5/14/202200:05TRMNEvercore ISI Maintains Their Buy Rating on Aura Biosciences..
5/12/202216:37EDGARQuarterly Report (10-q)
5/12/202216:32EDGARCurrent Report Filing (8-k)
5/12/202216:15BWAura Biosciences Reports First Quarter 2022 Financial..
5/03/202216:05BWAura Biosciences Presents Preclinical Data Highlighting..